Home › Free Stock Grades › OABI
OmniAb, Inc. (OABI) Stock Grade
OABI · Healthcare
C
Market Cap
$687.2M
P/E Ratio
—
Revenue Growth (YoY)
-29.3%
Net Margin
-347.0%
Return on Equity
—
Dividend Yield
None
About OmniAb, Inc.'s fundamentals
OmniAb is a biotechnology company with a market capitalization of $687.2 million that is currently unprofitable, reporting a net loss in its latest annual statement with a net margin of -347.0%. The company experienced a significant revenue decline of 29.3% year-over-year, indicating contraction in its core business. With no dividend yield and negative profitability metrics, the company is in a loss-making phase typical of early-stage biotech firms, though the magnitude of the margin decline suggests substantial operating expenses relative to revenue.